albendazole has been researched along with Bigfoot Disease in 2 studies
Excerpt | Relevance | Reference |
---|---|---|
"Because lymphatic filariasis (LF) elimination efforts are hampered by a dearth of economic information about the cost of mass drug administration (MDA) programs (using either albendazole with diethylcarbamazine [DEC] or albendazole with ivermectin), a multicenter study was undertaken to determine the costs of MDA programs to interrupt transmission of infection with LF." | 1.34 | National mass drug administration costs for lymphatic filariasis elimination. ( Aikins, M; Amarillo, ML; Belizario, VY; Brady, MA; Garshong, B; Goldman, AS; Guisinger, VH; Gyapong, J; Haddix, AC; Kabali, C; Kamal, HA; Kanjilal, S; Kyelem, D; Lizardo, J; Malecela, M; Mubyazi, G; Nitièma, PA; Ottesen, EA; Ramzy, RM; Rheingans, R; Streit, TG; Wallace, A, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goldman, AS | 1 |
Guisinger, VH | 1 |
Aikins, M | 1 |
Amarillo, ML | 1 |
Belizario, VY | 1 |
Garshong, B | 1 |
Gyapong, J | 1 |
Kabali, C | 1 |
Kamal, HA | 1 |
Kanjilal, S | 1 |
Kyelem, D | 1 |
Lizardo, J | 1 |
Malecela, M | 1 |
Mubyazi, G | 1 |
Nitièma, PA | 1 |
Ramzy, RM | 1 |
Streit, TG | 1 |
Wallace, A | 1 |
Brady, MA | 1 |
Rheingans, R | 1 |
Ottesen, EA | 1 |
Haddix, AC | 1 |
Stingl, P | 1 |
2 other studies available for albendazole and Bigfoot Disease
Article | Year |
---|---|
National mass drug administration costs for lymphatic filariasis elimination.
Topics: Albendazole; Anthelmintics; Burkina Faso; Costs and Cost Analysis; Diethylcarbamazine; Dominican Rep | 2007 |
[Elephantiasis soon eliminated? New therapeutic concepts make mass treatment possible].
Topics: Albendazole; Diethylcarbamazine; Drug Administration Schedule; Elephantiasis; Filaricides; Humans; I | 2000 |